← IBDology · Patient & Provider Resources · Indeterminate colitis (IBDu)
Indeterminate colitis & IBD-unclassified (IBDu)
When colitis doesn’t fit neatly into ulcerative colitis or Crohn’s — what that means for diagnosis, treatment, and pouch surgery.
Sometimes a chronic colitis has features of both ulcerative colitis (UC) and Crohn’s disease (CD), and a confident label can’t be assigned even after a complete workup. When that happens before surgery, clinicians often call it IBD-unclassified (IBDu); when it’s a pathologist’s reading of a removed colon, the older term is indeterminate colitis. Roughly 1 in 10 people with IBD colitis fall into this group, and the picture can sharpen over time.
What is indeterminate colitis / IBDu?
“Indeterminate colitis” and “IBD-unclassified” describe a chronic inflammatory bowel disease confined to the colon that cannot be definitively classified as UC or CD after a full evaluation — clinical history, colonoscopy with biopsies, imaging of the small bowel, and exclusion of infection. The two terms are used in slightly different settings, but both mean the same thing for the patient: the colitis is real, but it doesn’t read cleanly as one disease or the other.
How IBDu differs from UC and CD
- Overlapping features — continuous colonic inflammation like UC, but with patchy areas, deeper inflammation, or other findings that raise the question of CD.
- No small-bowel or perianal Crohn’s — by definition IBDu lacks the classic CD features (small-bowel disease, fistulas, granulomas) that would make the diagnosis Crohn’s.
- Diagnosis can evolve — over years of follow-up a meaningful share of people are reclassified as UC or CD as the disease declares itself.
How it’s diagnosed — and why it can change For clinicians
IBDu is a diagnosis of careful exclusion: rule out infection and other mimics, assess the small bowel (often with MR enterography), and review endoscopic and histologic patterns. Serologic markers (such as ASCA and pANCA) have limited discriminatory value and should not be relied on alone. Because the phenotype can shift, the label is best treated as provisional and revisited at follow-up rather than fixed at first diagnosis.
Treatment approach
Day-to-day treatment of IBDu generally mirrors the treatment of ulcerative colitis — the same families of medications are used to control inflammation and maintain remission. If the disease later behaves like Crohn’s, the plan is adjusted accordingly. The goal is the same as in any IBD: durable remission, mucosal healing, and avoiding complications.
Pouch surgery when the diagnosis is IBDu
If medical therapy no longer controls the colitis, removing the colon with an ileal pouch–anal anastomosis (J-pouch / IPAA) can be offered to selected people with IBDu — it is not automatically ruled out the way a confirmed Crohn’s diagnosis often is.
- Pouch outcomes in IBDu tend to fall between those of UC and Crohn’s.
- Rates of pouchitis and later “Crohn’s-like” disease of the pouch are somewhat higher than in pure UC, so counseling and follow-up matter.
- Because some people are later reclassified as CD, an honest pre-operative conversation about that possibility is part of informed consent.
What to ask your doctor
- Is my diagnosis ulcerative colitis, Crohn’s, or unclassified — and could it change over time?
- What features made my colitis hard to classify?
- If I need surgery, am I a candidate for a J-pouch, and what are my specific risks?
- How will you monitor whether my disease is behaving more like UC or Crohn’s?
- Should my care be at a high-volume IBD surgery center?
Ask about IBDu
Ask a question about indeterminate colitis and IBD-unclassified. Answers are grounded in the medical literature.
Educational information only — not a substitute for advice from your own care team. In an emergency call 911.